 | • レポートコード：D005-00888 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、性感染症（STD）診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。性感染症（STD）診断の種類別市場規模（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、ヒト免疫不全ウイルス検査）、用途別市場規模（政府機関、病院、診断クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、BioMérieux、Aposcience、Roche、Biocartis、Thermo Fisher Scientific、Cepheid、BD Medical、BCR Diagnostics、Bio-Rad、Hologic、Danaher、OraSure Technologies、GenMark Diagnostics、DiaSorin、Qualigen、Quidel ・地域別グローバル市場分析 2015年-2020年 ・性感染症（STD）診断の北米市場（アメリカ、カナダ、メキシコ） ・性感染症（STD）診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・性感染症（STD）診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・性感染症（STD）診断の南米市場（ブラジル、アルゼンチン） ・性感染症（STD）診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、ヒト免疫不全ウイルス検査 ・用途別分析：政府機関、病院、診断クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Sexually Transmitted Disease (STD) Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sexually Transmitted Disease (STD) Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sexually Transmitted Disease (STD) Diagnosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sexually Transmitted Disease (STD) Diagnosis market has been segmented into:
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
By Application, Sexually Transmitted Disease (STD) Diagnosis has been segmented into:
Government organizations
Hospitals
Diagnostic clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sexually Transmitted Disease (STD) Diagnosis market presented in the report. This section sheds light on the sales growth of different regional and country-level Sexually Transmitted Disease (STD) Diagnosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sexually Transmitted Disease (STD) Diagnosis market.
The report offers in-depth assessment of the growth and other aspects of the Sexually Transmitted Disease (STD) Diagnosis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sexually Transmitted Disease (STD) Diagnosis Market Share Analysis
Sexually Transmitted Disease (STD) Diagnosis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sexually Transmitted Disease (STD) Diagnosis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sexually Transmitted Disease (STD) Diagnosis sales, revenue and market share for each player covered in this report.
The major players covered in Sexually Transmitted Disease (STD) Diagnosis are:
Abbott
BioMérieux
Aposcience
Roche
Biocartis
Thermo Fisher Scientific
Cepheid
BD Medical
BCR Diagnostics
Bio-Rad
Hologic
Danaher
OraSure Technologies
GenMark Diagnostics
DiaSorin
Qualigen
Quidel
Table of Contents
1 Sexually Transmitted Disease (STD) Diagnosis Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Disease (STD) Diagnosis
1.2 Classification of Sexually Transmitted Disease (STD) Diagnosis by Type
1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type in 2019
1.2.3 Chlamydia testing
1.2.4 Syphilis testing
1.2.5 Gonorrhoea testing
1.2.6 Herpes simplex virus testing
1.2.7 Human papilloma virus testing
1.2.8 Human immunodeficiency virus testing
1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market by Application
1.3.1 Overview: Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Global Sexually Transmitted Disease (STD) Diagnosis Market by Regions
1.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sexually Transmitted Disease (STD) Diagnosis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioMérieux
2.2.1 BioMérieux Details
2.2.2 BioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioMérieux SWOT Analysis
2.2.4 BioMérieux Product and Services
2.2.5 BioMérieux Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aposcience
2.3.1 Aposcience Details
2.3.2 Aposcience Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aposcience SWOT Analysis
2.3.4 Aposcience Product and Services
2.3.5 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biocartis
2.5.1 Biocartis Details
2.5.2 Biocartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biocartis SWOT Analysis
2.5.4 Biocartis Product and Services
2.5.5 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cepheid
2.7.1 Cepheid Details
2.7.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cepheid SWOT Analysis
2.7.4 Cepheid Product and Services
2.7.5 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.8 BD Medical
2.8.1 BD Medical Details
2.8.2 BD Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BD Medical SWOT Analysis
2.8.4 BD Medical Product and Services
2.8.5 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.9 BCR Diagnostics
2.9.1 BCR Diagnostics Details
2.9.2 BCR Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BCR Diagnostics SWOT Analysis
2.9.4 BCR Diagnostics Product and Services
2.9.5 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-Rad
2.10.1 Bio-Rad Details
2.10.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-Rad SWOT Analysis
2.10.4 Bio-Rad Product and Services
2.10.5 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hologic
2.11.1 Hologic Details
2.11.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hologic SWOT Analysis
2.11.4 Hologic Product and Services
2.11.5 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.12 Danaher
2.12.1 Danaher Details
2.12.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Danaher SWOT Analysis
2.12.4 Danaher Product and Services
2.12.5 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.13 OraSure Technologies
2.13.1 OraSure Technologies Details
2.13.2 OraSure Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 OraSure Technologies SWOT Analysis
2.13.4 OraSure Technologies Product and Services
2.13.5 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.14 GenMark Diagnostics
2.14.1 GenMark Diagnostics Details
2.14.2 GenMark Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 GenMark Diagnostics SWOT Analysis
2.14.4 GenMark Diagnostics Product and Services
2.14.5 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.15 DiaSorin
2.15.1 DiaSorin Details
2.15.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 DiaSorin SWOT Analysis
2.15.4 DiaSorin Product and Services
2.15.5 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.16 Qualigen
2.16.1 Qualigen Details
2.16.2 Qualigen Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Qualigen SWOT Analysis
2.16.4 Qualigen Product and Services
2.16.5 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.17 Quidel
2.17.1 Quidel Details
2.17.2 Quidel Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Quidel SWOT Analysis
2.17.4 Quidel Product and Services
2.17.5 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexually Transmitted Disease (STD) Diagnosis Players Market Share
3.2.2 Top 10 Sexually Transmitted Disease (STD) Diagnosis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Market Share by Regions
4.2 North America Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
4.3 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
4.5 South America Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
5 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
5.1 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
5.2 USA Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
5.3 Canada Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
5.4 Mexico Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
6 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
6.1 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
6.2 Germany Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
6.3 UK Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
6.4 France Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
6.5 Russia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
6.6 Italy Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
7.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
7.2 China Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
7.3 Japan Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
7.4 Korea Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
7.5 India Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
8 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
8.1 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
8.2 Brazil Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
8.3 Argentina Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sexually Transmitted Disease (STD) Diagnosis by Countries
9.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
9.3 UAE Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
9.4 Egypt Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
9.5 South Africa Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Market Share by Type (2015-2020)
10.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Type (2019-2024)
10.3 Chlamydia testing Revenue Growth Rate (2015-2025)
10.4 Syphilis testing Revenue Growth Rate (2015-2025)
10.5 Gonorrhoea testing Revenue Growth Rate (2015-2025)
10.6 Herpes simplex virus testing Revenue Growth Rate (2015-2025)
10.7 Human papilloma virus testing Revenue Growth Rate (2015-2025)
10.8 Human immunodeficiency virus testing Revenue Growth Rate (2015-2025)
11 Global Sexually Transmitted Disease (STD) Diagnosis Market Segment by Application
11.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2015-2020)
11.2 Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Application (2019-2024)
11.3 Government organizations Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Diagnostic clinics Revenue Growth (2015-2020)
12 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast (2021-2025)
12.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast (2021-2025)
12.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Regions (2021-2025)
12.3 North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
12.4 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
12.6 South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sexually Transmitted Disease (STD) Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 7. Abbott Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 10. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. BioMérieux Corporate Information, Location and Competitors
Table 12. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 13. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2018-2019)
Table 14. BioMérieux SWOT Analysis
Table 15. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 16. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Aposcience Corporate Information, Location and Competitors
Table 18. Aposcience Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 19. Aposcience Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 20. Aposcience SWOT Analysis
Table 21. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 22. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 25. Roche Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 28. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Biocartis Corporate Information, Location and Competitors
Table 30. Biocartis Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 31. Biocartis Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 32. Biocartis SWOT Analysis
Table 33. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 34. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 36. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 37. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 38. Thermo Fisher Scientific SWOT Analysis
Table 39. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 40. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cepheid Corporate Information, Location and Competitors
Table 42. Cepheid Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 43. Cepheid Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 44. Cepheid SWOT Analysis
Table 45. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 46. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BD Medical Corporate Information, Location and Competitors
Table 48. BD Medical Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 49. BD Medical Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 50. BD Medical SWOT Analysis
Table 51. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 52. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BCR Diagnostics Corporate Information, Location and Competitors
Table 54. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 55. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 56. BCR Diagnostics SWOT Analysis
Table 57. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 58. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bio-Rad Corporate Information, Location and Competitors
Table 60. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 61. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 62. Bio-Rad SWOT Analysis
Table 63. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 64. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Hologic Corporate Information, Location and Competitors
Table 66. Hologic Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 67. Hologic Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 68. Hologic SWOT Analysis
Table 69. Hologic Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 70. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Danaher Corporate Information, Location and Competitors
Table 72. Danaher Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 73. Danaher Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 74. Danaher SWOT Analysis
Table 75. Danaher Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 76. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. OraSure Technologies Corporate Information, Location and Competitors
Table 78. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 79. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 80. OraSure Technologies SWOT Analysis
Table 81. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 82. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. GenMark Diagnostics Corporate Information, Location and Competitors
Table 84. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 85. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 86. GenMark Diagnostics SWOT Analysis
Table 87. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 88. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. DiaSorin Corporate Information, Location and Competitors
Table 90. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 91. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 92. DiaSorin SWOT Analysis
Table 93. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 94. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Qualigen Corporate Information, Location and Competitors
Table 96. Qualigen Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 97. Qualigen Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 98. Qualigen SWOT Analysis
Table 99. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 100. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Quidel Corporate Information, Location and Competitors
Table 102. Quidel Sexually Transmitted Disease (STD) Diagnosis Major Business
Table 103. Quidel Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 104. Quidel SWOT Analysis
Table 105. Quidel Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 106. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) by Players (2015-2020)
Table 108. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Players (2015-2020)
Table 109. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Regions (2015-2020)
Table 111. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
Table 112. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 113. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2015-2020)
Table 116. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 119. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) by Type (2015-2020)
Table 120. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2015-2020)
Table 121. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Type (2021-2025)
Table 122. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2015-2020)
Table 123. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application (2015-2020)
Table 124. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Application (2021-2025)
Table 125. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sexually Transmitted Disease (STD) Diagnosis Picture
Figure 2. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type in 2019
Figure 3. Chlamydia testing Picture
Figure 4. Syphilis testing Picture
Figure 5. Gonorrhoea testing Picture
Figure 6. Herpes simplex virus testing Picture
Figure 7. Human papilloma virus testing Picture
Figure 8. Human immunodeficiency virus testing Picture
Figure 9. Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application in 2019
Figure 10. Government organizations Picture
Figure 11. Hospitals Picture
Figure 12. Diagnostic clinics Picture
Figure 13. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share in 2019
Figure 22. Global Top 10 Players Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Regions (2015-2020)
Figure 26. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Regions in 2018
Figure 27. North America Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 28. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 30. South America Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 32. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 33. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries in 2019
Figure 34. USA Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 35. Canada Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 37. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries in 2019
Figure 39. Germany Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 40. UK Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 41. France Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 42. Russia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 43. Italy Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries in 2019
Figure 46. China Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 47. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 48. Korea Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 49. India Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 51. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 52. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries in 2019
Figure 53. Brazil Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 58. UAE Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2020)
Figure 61. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2015-2020)
Figure 62. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type in 2019
Figure 63. Global Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Type (2021-2025)
Figure 64. Global Chlamydia testing Revenue Growth Rate (2015-2020)
Figure 65. Global Syphilis testing Revenue Growth Rate (2015-2020)
Figure 66. Global Gonorrhoea testing Revenue Growth Rate (2015-2020)
Figure 67. Global Herpes simplex virus testing Revenue Growth Rate (2015-2020)
Figure 68. Global Human papilloma virus testing Revenue Growth Rate (2015-2020)
Figure 69. Global Human immunodeficiency virus testing Revenue Growth Rate (2015-2020)
Figure 70. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application (2015-2020)
Figure 71. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application in 2019
Figure 72. Global Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Application (2021-2025)
Figure 73. Global Government organizations Revenue Growth Rate (2015-2020)
Figure 74. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 75. Global Diagnostic clinics Revenue Growth Rate (2015-2020)
Figure 76. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
Figure 80. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
Figure 82. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
微生物試験/臨床微生物の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Microbiology Testing/Clinical Microbiology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3742.6 million by 2025, from USD 3151 million in 2019.…- 遺伝病診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genetic Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Disease Di…
- 腸疾患検査＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Enteric Disease Testing and Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3273.4 million by 2025, from USD 3101.6 million in 2019. …
- クラミジア診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chlamydia Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chlamydia D…
- 感染症用POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …